Scope Summit 2025 Iqvia The 16th annual scope summit for clinical ops executives is a four day program focusing on advances and innovative solutions in all aspects of clinical trial innovation, planning, management, operations, and investment. As the 2025 scope summit ends, we reflect on an incredible week of learnings, collaboration and drug development innovation. the iqvia team was excited to be a part of scope again this year, where we engaged with industry leaders, shared our expertise, exchanged ideas and explored new opportunities to advance clinical research.
Scope Summit 2025 Iqvia Today, we kicked off the 2025 scope summit in orlando, fl., and the iqvia team is thrilled to join industry leaders, researchers and innovators to explore the latest advances in clinical operations and research. before the official start of scope, we hosted an iqvia technologies innovation day. Discover key insights from iqvia innovation day at scope summit 2025 on operationalizing patient centricity in clinical trials, including enhancing digital adoption, improving patient experience, and raising awareness through patient advocacy and healthcare technology. Scope 2025 convened 4,500 attendees (10% growth over 2024), 630 speakers, and 300 exhibitors (20% growth over 2024), with 60% in key decision making roles, cementing its position as the premier event for clinical trial innovation. Learn how ecoas ensure endpoint protection and optimize data analytics 1:05 pm, discover how iqvia's blend of saas and tech enabled services can streamline your budgeting and financial.
Scope Summit 2025 Iqvia Scope 2025 convened 4,500 attendees (10% growth over 2024), 630 speakers, and 300 exhibitors (20% growth over 2024), with 60% in key decision making roles, cementing its position as the premier event for clinical trial innovation. Learn how ecoas ensure endpoint protection and optimize data analytics 1:05 pm, discover how iqvia's blend of saas and tech enabled services can streamline your budgeting and financial. In an interview with act senior editor andy studna at scope summit, patil, vice president, digital innovation, iqvia, discusses how artificial intelligence machine learning can help in areas such as feasibility, site selection, and patient recruitment. Explore the latest keynote presentations at the scope summit europe, where leaders like kevin landells, vice president patient centered technology delivery, iqvia technologies share insights on innovation, digital trials, and strategies shaping the future of clinical research. At the request of our attendees, we have extended the coverage in 2025 on patient centric trial design, site engagement, recruitment, generative ai, small biopharma strategies, and other key topics. In an interview with act senior editor andy studna at scope summit, rajneesh patil, vice president, digital innovation, iqvia, highlights the impact of artificial intelligence machine learning in improving outcomes and maintaining safety with its implementation.
Scope Summit 2025 Iqvia In an interview with act senior editor andy studna at scope summit, patil, vice president, digital innovation, iqvia, discusses how artificial intelligence machine learning can help in areas such as feasibility, site selection, and patient recruitment. Explore the latest keynote presentations at the scope summit europe, where leaders like kevin landells, vice president patient centered technology delivery, iqvia technologies share insights on innovation, digital trials, and strategies shaping the future of clinical research. At the request of our attendees, we have extended the coverage in 2025 on patient centric trial design, site engagement, recruitment, generative ai, small biopharma strategies, and other key topics. In an interview with act senior editor andy studna at scope summit, rajneesh patil, vice president, digital innovation, iqvia, highlights the impact of artificial intelligence machine learning in improving outcomes and maintaining safety with its implementation.
Scope Summit 2025 Iqvia At the request of our attendees, we have extended the coverage in 2025 on patient centric trial design, site engagement, recruitment, generative ai, small biopharma strategies, and other key topics. In an interview with act senior editor andy studna at scope summit, rajneesh patil, vice president, digital innovation, iqvia, highlights the impact of artificial intelligence machine learning in improving outcomes and maintaining safety with its implementation.
Iqvia At Scope Summit 2025 Week Wrap Up Iqvia
Comments are closed.